Collegium Pharmaceutical (NASDAQ:COLL) Upgraded to Strong-Buy at Wall Street Zen
Wall Street Zen upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) from a buy rating to a strong-buy rating in a report issued on Saturday morning. Other equities analysts have also recently issued research reports about the stock. HC Wainwright restated a “buy” rating and issued a $50.00 price objective on shares of Collegium […]
Wall Street Zen upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) from a buy rating to a strong-buy rating in a report issued on Saturday morning. Other equities analysts have also recently issued research reports about the stock. HC Wainwright restated a “buy” rating and issued a $50.00 price objective on shares of Collegium […]
